Global Follicle Stimulating Hormone Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Follicle Stimulating Hormone market size was valued at US$ 1386 million in 2024 and is forecast to a readjusted size of USD 1670 million by 2031 with a CAGR of 2.7% during review period.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report is a detailed and comprehensive analysis for global Follicle Stimulating Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Follicle Stimulating Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Follicle Stimulating Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Follicle Stimulating Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Follicle Stimulating Hormone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone, with price, sales quantity, revenue, and global market share of Follicle Stimulating Hormone from 2020 to 2025.
Chapter 3, the Follicle Stimulating Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Follicle Stimulating Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone.
Chapter 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report is a detailed and comprehensive analysis for global Follicle Stimulating Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Follicle Stimulating Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Follicle Stimulating Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Follicle Stimulating Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Follicle Stimulating Hormone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Recombinant FSH
- Urinary FSH
- Infertility Treatment
- Assisted Reproductive Technology
- Merck Serono
- MSD
- IBSA
- Ferring
- Livzon
- Techwell
- GenSci
- Gedeon Richter
- Teva
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone, with price, sales quantity, revenue, and global market share of Follicle Stimulating Hormone from 2020 to 2025.
Chapter 3, the Follicle Stimulating Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Follicle Stimulating Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone.
Chapter 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Recombinant FSH
1.3.3 Urinary FSH
1.4 Market Analysis by Application
1.4.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infertility Treatment
1.4.3 Assisted Reproductive Technology
1.5 Global Follicle Stimulating Hormone Market Size & Forecast
1.5.1 Global Follicle Stimulating Hormone Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Follicle Stimulating Hormone Sales Quantity (2020-2031)
1.5.3 Global Follicle Stimulating Hormone Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Merck Serono
2.1.1 Merck Serono Details
2.1.2 Merck Serono Major Business
2.1.3 Merck Serono Follicle Stimulating Hormone Product and Services
2.1.4 Merck Serono Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Merck Serono Recent Developments/Updates
2.2 MSD
2.2.1 MSD Details
2.2.2 MSD Major Business
2.2.3 MSD Follicle Stimulating Hormone Product and Services
2.2.4 MSD Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 MSD Recent Developments/Updates
2.3 IBSA
2.3.1 IBSA Details
2.3.2 IBSA Major Business
2.3.3 IBSA Follicle Stimulating Hormone Product and Services
2.3.4 IBSA Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 IBSA Recent Developments/Updates
2.4 Ferring
2.4.1 Ferring Details
2.4.2 Ferring Major Business
2.4.3 Ferring Follicle Stimulating Hormone Product and Services
2.4.4 Ferring Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Ferring Recent Developments/Updates
2.5 Livzon
2.5.1 Livzon Details
2.5.2 Livzon Major Business
2.5.3 Livzon Follicle Stimulating Hormone Product and Services
2.5.4 Livzon Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Livzon Recent Developments/Updates
2.6 Techwell
2.6.1 Techwell Details
2.6.2 Techwell Major Business
2.6.3 Techwell Follicle Stimulating Hormone Product and Services
2.6.4 Techwell Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Techwell Recent Developments/Updates
2.7 GenSci
2.7.1 GenSci Details
2.7.2 GenSci Major Business
2.7.3 GenSci Follicle Stimulating Hormone Product and Services
2.7.4 GenSci Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 GenSci Recent Developments/Updates
2.8 Gedeon Richter
2.8.1 Gedeon Richter Details
2.8.2 Gedeon Richter Major Business
2.8.3 Gedeon Richter Follicle Stimulating Hormone Product and Services
2.8.4 Gedeon Richter Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gedeon Richter Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Follicle Stimulating Hormone Product and Services
2.9.4 Teva Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Teva Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FOLLICLE STIMULATING HORMONE BY MANUFACTURER
3.1 Global Follicle Stimulating Hormone Sales Quantity by Manufacturer (2020-2025)
3.2 Global Follicle Stimulating Hormone Revenue by Manufacturer (2020-2025)
3.3 Global Follicle Stimulating Hormone Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2024
3.4.3 Top 6 Follicle Stimulating Hormone Manufacturer Market Share in 2024
3.5 Follicle Stimulating Hormone Market: Overall Company Footprint Analysis
3.5.1 Follicle Stimulating Hormone Market: Region Footprint
3.5.2 Follicle Stimulating Hormone Market: Company Product Type Footprint
3.5.3 Follicle Stimulating Hormone Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Follicle Stimulating Hormone Market Size by Region
4.1.1 Global Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
4.1.2 Global Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
4.1.3 Global Follicle Stimulating Hormone Average Price by Region (2020-2031)
4.2 North America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.3 Europe Follicle Stimulating Hormone Consumption Value (2020-2031)
4.4 Asia-Pacific Follicle Stimulating Hormone Consumption Value (2020-2031)
4.5 South America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.6 Middle East & Africa Follicle Stimulating Hormone Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
5.2 Global Follicle Stimulating Hormone Consumption Value by Type (2020-2031)
5.3 Global Follicle Stimulating Hormone Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
6.2 Global Follicle Stimulating Hormone Consumption Value by Application (2020-2031)
6.3 Global Follicle Stimulating Hormone Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
7.2 North America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
7.3 North America Follicle Stimulating Hormone Market Size by Country
7.3.1 North America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
7.3.2 North America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
8.2 Europe Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
8.3 Europe Follicle Stimulating Hormone Market Size by Country
8.3.1 Europe Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
8.3.2 Europe Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Follicle Stimulating Hormone Market Size by Region
9.3.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
10.2 South America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
10.3 South America Follicle Stimulating Hormone Market Size by Country
10.3.1 South America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
10.3.2 South America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Follicle Stimulating Hormone Market Size by Country
11.3.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Follicle Stimulating Hormone Market Drivers
12.2 Follicle Stimulating Hormone Market Restraints
12.3 Follicle Stimulating Hormone Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Follicle Stimulating Hormone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone
13.3 Follicle Stimulating Hormone Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Follicle Stimulating Hormone Typical Distributors
14.3 Follicle Stimulating Hormone Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Recombinant FSH
1.3.3 Urinary FSH
1.4 Market Analysis by Application
1.4.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infertility Treatment
1.4.3 Assisted Reproductive Technology
1.5 Global Follicle Stimulating Hormone Market Size & Forecast
1.5.1 Global Follicle Stimulating Hormone Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Follicle Stimulating Hormone Sales Quantity (2020-2031)
1.5.3 Global Follicle Stimulating Hormone Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Merck Serono
2.1.1 Merck Serono Details
2.1.2 Merck Serono Major Business
2.1.3 Merck Serono Follicle Stimulating Hormone Product and Services
2.1.4 Merck Serono Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Merck Serono Recent Developments/Updates
2.2 MSD
2.2.1 MSD Details
2.2.2 MSD Major Business
2.2.3 MSD Follicle Stimulating Hormone Product and Services
2.2.4 MSD Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 MSD Recent Developments/Updates
2.3 IBSA
2.3.1 IBSA Details
2.3.2 IBSA Major Business
2.3.3 IBSA Follicle Stimulating Hormone Product and Services
2.3.4 IBSA Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 IBSA Recent Developments/Updates
2.4 Ferring
2.4.1 Ferring Details
2.4.2 Ferring Major Business
2.4.3 Ferring Follicle Stimulating Hormone Product and Services
2.4.4 Ferring Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Ferring Recent Developments/Updates
2.5 Livzon
2.5.1 Livzon Details
2.5.2 Livzon Major Business
2.5.3 Livzon Follicle Stimulating Hormone Product and Services
2.5.4 Livzon Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Livzon Recent Developments/Updates
2.6 Techwell
2.6.1 Techwell Details
2.6.2 Techwell Major Business
2.6.3 Techwell Follicle Stimulating Hormone Product and Services
2.6.4 Techwell Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Techwell Recent Developments/Updates
2.7 GenSci
2.7.1 GenSci Details
2.7.2 GenSci Major Business
2.7.3 GenSci Follicle Stimulating Hormone Product and Services
2.7.4 GenSci Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 GenSci Recent Developments/Updates
2.8 Gedeon Richter
2.8.1 Gedeon Richter Details
2.8.2 Gedeon Richter Major Business
2.8.3 Gedeon Richter Follicle Stimulating Hormone Product and Services
2.8.4 Gedeon Richter Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gedeon Richter Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Follicle Stimulating Hormone Product and Services
2.9.4 Teva Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Teva Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FOLLICLE STIMULATING HORMONE BY MANUFACTURER
3.1 Global Follicle Stimulating Hormone Sales Quantity by Manufacturer (2020-2025)
3.2 Global Follicle Stimulating Hormone Revenue by Manufacturer (2020-2025)
3.3 Global Follicle Stimulating Hormone Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2024
3.4.3 Top 6 Follicle Stimulating Hormone Manufacturer Market Share in 2024
3.5 Follicle Stimulating Hormone Market: Overall Company Footprint Analysis
3.5.1 Follicle Stimulating Hormone Market: Region Footprint
3.5.2 Follicle Stimulating Hormone Market: Company Product Type Footprint
3.5.3 Follicle Stimulating Hormone Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Follicle Stimulating Hormone Market Size by Region
4.1.1 Global Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
4.1.2 Global Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
4.1.3 Global Follicle Stimulating Hormone Average Price by Region (2020-2031)
4.2 North America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.3 Europe Follicle Stimulating Hormone Consumption Value (2020-2031)
4.4 Asia-Pacific Follicle Stimulating Hormone Consumption Value (2020-2031)
4.5 South America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.6 Middle East & Africa Follicle Stimulating Hormone Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
5.2 Global Follicle Stimulating Hormone Consumption Value by Type (2020-2031)
5.3 Global Follicle Stimulating Hormone Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
6.2 Global Follicle Stimulating Hormone Consumption Value by Application (2020-2031)
6.3 Global Follicle Stimulating Hormone Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
7.2 North America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
7.3 North America Follicle Stimulating Hormone Market Size by Country
7.3.1 North America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
7.3.2 North America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
8.2 Europe Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
8.3 Europe Follicle Stimulating Hormone Market Size by Country
8.3.1 Europe Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
8.3.2 Europe Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Follicle Stimulating Hormone Market Size by Region
9.3.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
10.2 South America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
10.3 South America Follicle Stimulating Hormone Market Size by Country
10.3.1 South America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
10.3.2 South America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Follicle Stimulating Hormone Market Size by Country
11.3.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Follicle Stimulating Hormone Market Drivers
12.2 Follicle Stimulating Hormone Market Restraints
12.3 Follicle Stimulating Hormone Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Follicle Stimulating Hormone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone
13.3 Follicle Stimulating Hormone Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Follicle Stimulating Hormone Typical Distributors
14.3 Follicle Stimulating Hormone Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Follicle Stimulating Hormone Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 4. Merck Serono Major Business
Table 5. Merck Serono Follicle Stimulating Hormone Product and Services
Table 6. Merck Serono Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Merck Serono Recent Developments/Updates
Table 8. MSD Basic Information, Manufacturing Base and Competitors
Table 9. MSD Major Business
Table 10. MSD Follicle Stimulating Hormone Product and Services
Table 11. MSD Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. MSD Recent Developments/Updates
Table 13. IBSA Basic Information, Manufacturing Base and Competitors
Table 14. IBSA Major Business
Table 15. IBSA Follicle Stimulating Hormone Product and Services
Table 16. IBSA Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. IBSA Recent Developments/Updates
Table 18. Ferring Basic Information, Manufacturing Base and Competitors
Table 19. Ferring Major Business
Table 20. Ferring Follicle Stimulating Hormone Product and Services
Table 21. Ferring Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Ferring Recent Developments/Updates
Table 23. Livzon Basic Information, Manufacturing Base and Competitors
Table 24. Livzon Major Business
Table 25. Livzon Follicle Stimulating Hormone Product and Services
Table 26. Livzon Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Livzon Recent Developments/Updates
Table 28. Techwell Basic Information, Manufacturing Base and Competitors
Table 29. Techwell Major Business
Table 30. Techwell Follicle Stimulating Hormone Product and Services
Table 31. Techwell Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Techwell Recent Developments/Updates
Table 33. GenSci Basic Information, Manufacturing Base and Competitors
Table 34. GenSci Major Business
Table 35. GenSci Follicle Stimulating Hormone Product and Services
Table 36. GenSci Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. GenSci Recent Developments/Updates
Table 38. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 39. Gedeon Richter Major Business
Table 40. Gedeon Richter Follicle Stimulating Hormone Product and Services
Table 41. Gedeon Richter Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Gedeon Richter Recent Developments/Updates
Table 43. Teva Basic Information, Manufacturing Base and Competitors
Table 44. Teva Major Business
Table 45. Teva Follicle Stimulating Hormone Product and Services
Table 46. Teva Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Teva Recent Developments/Updates
Table 48. Global Follicle Stimulating Hormone Sales Quantity by Manufacturer (2020-2025) & (K Doses)
Table 49. Global Follicle Stimulating Hormone Revenue by Manufacturer (2020-2025) & (USD Million)
Table 50. Global Follicle Stimulating Hormone Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 51. Market Position of Manufacturers in Follicle Stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 52. Head Office and Follicle Stimulating Hormone Production Site of Key Manufacturer
Table 53. Follicle Stimulating Hormone Market: Company Product Type Footprint
Table 54. Follicle Stimulating Hormone Market: Company Product Application Footprint
Table 55. Follicle Stimulating Hormone New Market Entrants and Barriers to Market Entry
Table 56. Follicle Stimulating Hormone Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Follicle Stimulating Hormone Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 58. Global Follicle Stimulating Hormone Sales Quantity by Region (2020-2025) & (K Doses)
Table 59. Global Follicle Stimulating Hormone Sales Quantity by Region (2026-2031) & (K Doses)
Table 60. Global Follicle Stimulating Hormone Consumption Value by Region (2020-2025) & (USD Million)
Table 61. Global Follicle Stimulating Hormone Consumption Value by Region (2026-2031) & (USD Million)
Table 62. Global Follicle Stimulating Hormone Average Price by Region (2020-2025) & (USD/Dose)
Table 63. Global Follicle Stimulating Hormone Average Price by Region (2026-2031) & (USD/Dose)
Table 64. Global Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 65. Global Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 66. Global Follicle Stimulating Hormone Consumption Value by Type (2020-2025) & (USD Million)
Table 67. Global Follicle Stimulating Hormone Consumption Value by Type (2026-2031) & (USD Million)
Table 68. Global Follicle Stimulating Hormone Average Price by Type (2020-2025) & (USD/Dose)
Table 69. Global Follicle Stimulating Hormone Average Price by Type (2026-2031) & (USD/Dose)
Table 70. Global Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 71. Global Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 72. Global Follicle Stimulating Hormone Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Global Follicle Stimulating Hormone Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Global Follicle Stimulating Hormone Average Price by Application (2020-2025) & (USD/Dose)
Table 75. Global Follicle Stimulating Hormone Average Price by Application (2026-2031) & (USD/Dose)
Table 76. North America Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 77. North America Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 78. North America Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 79. North America Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 80. North America Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 81. North America Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 82. North America Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 85. Europe Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 86. Europe Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 87. Europe Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 88. Europe Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 89. Europe Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 90. Europe Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 91. Europe Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 93. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 94. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 95. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 96. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2020-2025) & (K Doses)
Table 97. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2026-2031) & (K Doses)
Table 98. Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2020-2025) & (USD Million)
Table 99. Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2026-2031) & (USD Million)
Table 100. South America Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 101. South America Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 102. South America Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 103. South America Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 104. South America Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 105. South America Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 106. South America Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 107. South America Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 109. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 110. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 111. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 112. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 113. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 114. Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 115. Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 116. Follicle Stimulating Hormone Raw Material
Table 117. Key Manufacturers of Follicle Stimulating Hormone Raw Materials
Table 118. Follicle Stimulating Hormone Typical Distributors
Table 119. Follicle Stimulating Hormone Typical Customers
Table 1. Global Follicle Stimulating Hormone Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 4. Merck Serono Major Business
Table 5. Merck Serono Follicle Stimulating Hormone Product and Services
Table 6. Merck Serono Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Merck Serono Recent Developments/Updates
Table 8. MSD Basic Information, Manufacturing Base and Competitors
Table 9. MSD Major Business
Table 10. MSD Follicle Stimulating Hormone Product and Services
Table 11. MSD Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. MSD Recent Developments/Updates
Table 13. IBSA Basic Information, Manufacturing Base and Competitors
Table 14. IBSA Major Business
Table 15. IBSA Follicle Stimulating Hormone Product and Services
Table 16. IBSA Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. IBSA Recent Developments/Updates
Table 18. Ferring Basic Information, Manufacturing Base and Competitors
Table 19. Ferring Major Business
Table 20. Ferring Follicle Stimulating Hormone Product and Services
Table 21. Ferring Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Ferring Recent Developments/Updates
Table 23. Livzon Basic Information, Manufacturing Base and Competitors
Table 24. Livzon Major Business
Table 25. Livzon Follicle Stimulating Hormone Product and Services
Table 26. Livzon Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Livzon Recent Developments/Updates
Table 28. Techwell Basic Information, Manufacturing Base and Competitors
Table 29. Techwell Major Business
Table 30. Techwell Follicle Stimulating Hormone Product and Services
Table 31. Techwell Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Techwell Recent Developments/Updates
Table 33. GenSci Basic Information, Manufacturing Base and Competitors
Table 34. GenSci Major Business
Table 35. GenSci Follicle Stimulating Hormone Product and Services
Table 36. GenSci Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. GenSci Recent Developments/Updates
Table 38. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 39. Gedeon Richter Major Business
Table 40. Gedeon Richter Follicle Stimulating Hormone Product and Services
Table 41. Gedeon Richter Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Gedeon Richter Recent Developments/Updates
Table 43. Teva Basic Information, Manufacturing Base and Competitors
Table 44. Teva Major Business
Table 45. Teva Follicle Stimulating Hormone Product and Services
Table 46. Teva Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Teva Recent Developments/Updates
Table 48. Global Follicle Stimulating Hormone Sales Quantity by Manufacturer (2020-2025) & (K Doses)
Table 49. Global Follicle Stimulating Hormone Revenue by Manufacturer (2020-2025) & (USD Million)
Table 50. Global Follicle Stimulating Hormone Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 51. Market Position of Manufacturers in Follicle Stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 52. Head Office and Follicle Stimulating Hormone Production Site of Key Manufacturer
Table 53. Follicle Stimulating Hormone Market: Company Product Type Footprint
Table 54. Follicle Stimulating Hormone Market: Company Product Application Footprint
Table 55. Follicle Stimulating Hormone New Market Entrants and Barriers to Market Entry
Table 56. Follicle Stimulating Hormone Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Follicle Stimulating Hormone Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 58. Global Follicle Stimulating Hormone Sales Quantity by Region (2020-2025) & (K Doses)
Table 59. Global Follicle Stimulating Hormone Sales Quantity by Region (2026-2031) & (K Doses)
Table 60. Global Follicle Stimulating Hormone Consumption Value by Region (2020-2025) & (USD Million)
Table 61. Global Follicle Stimulating Hormone Consumption Value by Region (2026-2031) & (USD Million)
Table 62. Global Follicle Stimulating Hormone Average Price by Region (2020-2025) & (USD/Dose)
Table 63. Global Follicle Stimulating Hormone Average Price by Region (2026-2031) & (USD/Dose)
Table 64. Global Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 65. Global Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 66. Global Follicle Stimulating Hormone Consumption Value by Type (2020-2025) & (USD Million)
Table 67. Global Follicle Stimulating Hormone Consumption Value by Type (2026-2031) & (USD Million)
Table 68. Global Follicle Stimulating Hormone Average Price by Type (2020-2025) & (USD/Dose)
Table 69. Global Follicle Stimulating Hormone Average Price by Type (2026-2031) & (USD/Dose)
Table 70. Global Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 71. Global Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 72. Global Follicle Stimulating Hormone Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Global Follicle Stimulating Hormone Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Global Follicle Stimulating Hormone Average Price by Application (2020-2025) & (USD/Dose)
Table 75. Global Follicle Stimulating Hormone Average Price by Application (2026-2031) & (USD/Dose)
Table 76. North America Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 77. North America Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 78. North America Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 79. North America Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 80. North America Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 81. North America Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 82. North America Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 85. Europe Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 86. Europe Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 87. Europe Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 88. Europe Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 89. Europe Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 90. Europe Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 91. Europe Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 93. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 94. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 95. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 96. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2020-2025) & (K Doses)
Table 97. Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2026-2031) & (K Doses)
Table 98. Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2020-2025) & (USD Million)
Table 99. Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2026-2031) & (USD Million)
Table 100. South America Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 101. South America Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 102. South America Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 103. South America Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 104. South America Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 105. South America Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 106. South America Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 107. South America Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2020-2025) & (K Doses)
Table 109. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2026-2031) & (K Doses)
Table 110. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2020-2025) & (K Doses)
Table 111. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2026-2031) & (K Doses)
Table 112. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2020-2025) & (K Doses)
Table 113. Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2026-2031) & (K Doses)
Table 114. Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2020-2025) & (USD Million)
Table 115. Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2026-2031) & (USD Million)
Table 116. Follicle Stimulating Hormone Raw Material
Table 117. Key Manufacturers of Follicle Stimulating Hormone Raw Materials
Table 118. Follicle Stimulating Hormone Typical Distributors
Table 119. Follicle Stimulating Hormone Typical Customers
LIST OF FIGURES
Figure 1. Follicle Stimulating Hormone Picture
Figure 2. Global Follicle Stimulating Hormone Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Follicle Stimulating Hormone Revenue Market Share by Type in 2024
Figure 4. Recombinant FSH Examples
Figure 5. Urinary FSH Examples
Figure 6. Global Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Follicle Stimulating Hormone Revenue Market Share by Application in 2024
Figure 8. Infertility Treatment Examples
Figure 9. Assisted Reproductive Technology Examples
Figure 10. Global Follicle Stimulating Hormone Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Follicle Stimulating Hormone Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Follicle Stimulating Hormone Sales Quantity (2020-2031) & (K Doses)
Figure 13. Global Follicle Stimulating Hormone Price (2020-2031) & (USD/Dose)
Figure 14. Global Follicle Stimulating Hormone Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Follicle Stimulating Hormone by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Follicle Stimulating Hormone Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Follicle Stimulating Hormone Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Follicle Stimulating Hormone Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Follicle Stimulating Hormone Average Price by Type (2020-2031) & (USD/Dose)
Figure 29. Global Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Follicle Stimulating Hormone Revenue Market Share by Application (2020-2031)
Figure 31. Global Follicle Stimulating Hormone Average Price by Application (2020-2031) & (USD/Dose)
Figure 32. North America Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 44. France Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Follicle Stimulating Hormone Consumption Value Market Share by Region (2020-2031)
Figure 52. China Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 55. India Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 72. Follicle Stimulating Hormone Market Drivers
Figure 73. Follicle Stimulating Hormone Market Restraints
Figure 74. Follicle Stimulating Hormone Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone in 2024
Figure 77. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 78. Follicle Stimulating Hormone Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Follicle Stimulating Hormone Picture
Figure 2. Global Follicle Stimulating Hormone Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Follicle Stimulating Hormone Revenue Market Share by Type in 2024
Figure 4. Recombinant FSH Examples
Figure 5. Urinary FSH Examples
Figure 6. Global Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Follicle Stimulating Hormone Revenue Market Share by Application in 2024
Figure 8. Infertility Treatment Examples
Figure 9. Assisted Reproductive Technology Examples
Figure 10. Global Follicle Stimulating Hormone Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Follicle Stimulating Hormone Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Follicle Stimulating Hormone Sales Quantity (2020-2031) & (K Doses)
Figure 13. Global Follicle Stimulating Hormone Price (2020-2031) & (USD/Dose)
Figure 14. Global Follicle Stimulating Hormone Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Follicle Stimulating Hormone by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Follicle Stimulating Hormone Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Follicle Stimulating Hormone Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Follicle Stimulating Hormone Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Follicle Stimulating Hormone Average Price by Type (2020-2031) & (USD/Dose)
Figure 29. Global Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Follicle Stimulating Hormone Revenue Market Share by Application (2020-2031)
Figure 31. Global Follicle Stimulating Hormone Average Price by Application (2020-2031) & (USD/Dose)
Figure 32. North America Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 44. France Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Follicle Stimulating Hormone Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Follicle Stimulating Hormone Consumption Value Market Share by Region (2020-2031)
Figure 52. China Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 55. India Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Follicle Stimulating Hormone Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Follicle Stimulating Hormone Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Follicle Stimulating Hormone Consumption Value (2020-2031) & (USD Million)
Figure 72. Follicle Stimulating Hormone Market Drivers
Figure 73. Follicle Stimulating Hormone Market Restraints
Figure 74. Follicle Stimulating Hormone Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone in 2024
Figure 77. Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure 78. Follicle Stimulating Hormone Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
